View Item 

Show simple item record

Using race to estimate glomerular filtration and its impact in kidney transplantation
dc.contributor.authorKuppachi, Sarat
dc.contributor.authorNorman, Silas P.
dc.contributor.authorLentine, Krista L.
dc.contributor.authorAxelrod, David A.
dc.date.accessioned2021-02-04T21:50:22Z
dc.date.available2022-02-04 16:50:20en
dc.date.available2021-02-04T21:50:22Z
dc.date.issued2021-01
dc.identifier.citationKuppachi, Sarat; Norman, Silas P.; Lentine, Krista L.; Axelrod, David A. (2021). "Using race to estimate glomerular filtration and its impact in kidney transplantation." Clinical Transplantation (1): n/a-n/a.
dc.identifier.issn0902-0063
dc.identifier.issn1399-0012
dc.identifier.urihttps://hdl.handle.net/2027.42/166197
dc.description.abstractSince direct measurement of glomerular filtration rate (GFR) is time‐consuming and more expensive, estimated GFR (eGFR) based on measured laboratory values is widely used to determine kidney function. Commonly used formulae to calculate eGFR are dependent on variables, which include filtration markers like serum creatinine and patient characteristics including race. Medical algorithms which utilize race are increasingly being scrutinized, as race is recognized to be a social construct rather than a biologic one. eGFR calculations have important implications for kidney transplantation, both in the listing of candidates as well as in the evaluation of potential kidney donors. This review considers the specific implications of race‐based eGFR calculations on recipient evaluation and on decisions related to living kidney donation. We suggest a potential policy solution to ensure that racial and ethnic minority patients are not disadvantaged by eGFR as a result of current calculation methods.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherdisparities
dc.subject.otherOrgan Procurement and Transplantation Network
dc.subject.otherrace
dc.subject.otherliving
dc.subject.otherglomerular filtration rate
dc.subject.otherethnicity
dc.subject.otherdonors and donation
dc.titleUsing race to estimate glomerular filtration and its impact in kidney transplantation
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166197/1/ctr14136.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166197/2/ctr14136_am.pdf
dc.identifier.doi10.1111/ctr.14136
dc.identifier.doihttps://dx.doi.org/10.7302/120
dc.identifier.sourceClinical Transplantation
dc.identifier.citedreferenceJulian BA, Gaston RS, Brown WM, et al. Effect of replacing race with apolipoprotein L1 genotype in calculation of kidney donor risk index. Am J Transplant. 2017; 17 ( 6 ): 1540 ‐ 1548.
dc.identifier.citedreferenceHsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end‐stage renal disease in the United States. J Am Soc Nephrol. 2003; 14 ( 11 ): 2902 ‐ 2907.
dc.identifier.citedreferenceBrancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end‐stage renal disease among blacks. A population‐based study of potential explanatory factors. JAMA. 1992; 268 ( 21 ): 3079 ‐ 3084.
dc.identifier.citedreferenceBuchmueller TC, Levy HG. The ACA’s impact on racial and ethnic disparities in health insurance coverage and access to care. Health Aff (Millwood). 2020; 39 ( 3 ): 395 ‐ 402.
dc.identifier.citedreferenceParsa A, Kao WH, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013; 369 ( 23 ): 2183 ‐ 2196.
dc.identifier.citedreferenceDummer PD, Limou S, Rosenberg AZ, et al. APOL1 kidney disease risk variants: an evolving landscape. Semin Nephrol. 2015; 35 ( 3 ): 222 ‐ 236.
dc.identifier.citedreferencePrevention CfDCa. Chronic Kidney Disease (CKD) surveillance system. CKD Risk Calculators. 2020.
dc.identifier.citedreferenceMartins D, Agodoa L, Norris KC. Hypertensive chronic kidney disease in African Americans: strategies for improving care. Cleve Clin J Med. 2012; 79 ( 10 ): 726 ‐ 734.
dc.identifier.citedreferencePeralta CA, Hicks LS, Chertow GM, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005; 45 ( 6 ): 1119 ‐ 1124.
dc.identifier.citedreferenceHounkpatin HO, Fraser SDS, Honney R, Dreyer G, Brettle A, Roderick PJ. Ethnic minority disparities in progression and mortality of pre‐dialysis chronic kidney disease: a systematic scoping review. BMC Nephrol. 2020; 21 ( 1 ): 217.
dc.identifier.citedreferenceKumar K, Tonascia JM, Muzaale AD, et al. Racial differences in completion of the living kidney donor evaluation process. Clin Transplant. 2018; 32 ( 7 ): e13291.
dc.identifier.citedreferenceMurphy KA, Jackson JW, Purnell TS, et al. Association of socioeconomic status and comorbidities with racial disparities during kidney transplant evaluation. Clin J Am Soc Nephrol. 2020; 15 ( 6 ): 843 ‐ 851.
dc.identifier.citedreferenceWilliams WW, Delmonico FL. The end of racial disparities in kidney transplantation? Not so fast!. J Am Soc Nephrol. 2016; 27 ( 8 ): 2224 ‐ 2226.
dc.identifier.citedreferenceSchold JD, Gregg JA, Harman JS, Hall AG, Patton PR, Meier‐Kriesche HU. Barriers to evaluation and wait listing for kidney transplantation. Clin J Am Soc Nephrol. 2011; 6 ( 7 ): 1760 ‐ 1767.
dc.identifier.citedreferenceKasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol. 2002; 13 ( 5 ): 1358 ‐ 1364.
dc.identifier.citedreferenceNaylor KL, Kim SJ, McArthur E, Garg AX, McCallum MK, Knoll GA. Mortality in incident maintenance dialysis patients versus incident solid organ cancer patients: a population‐based cohort. Am J Kidney Dis. 2019; 73 ( 6 ): 765 ‐ 776.
dc.identifier.citedreferenceLentine KL, Mannon RB. Apolipoprotein L1: role in the evaluation of kidney transplant donors. Curr Opin Nephrol Hypertens. 2020; 29 ( 6 ): 645 ‐ 655.
dc.identifier.citedreferenceLiem YS, Weimar W. Early living‐donor kidney transplantation: a review of the associated survival benefit. Transplantation. 2009; 87 ( 3 ): 317 ‐ 318.
dc.identifier.citedreferenceGill J, Dong J, Rose C, Johnston O, Landsberg D, Gill J. The effect of race and income on living kidney donation in the United States. J Am Soc Nephrol. 2013; 24 ( 11 ): 1872 ‐ 1879.
dc.identifier.citedreferenceLentine KL, Mandelbrot D. Addressing disparities in living donor kidney transplantation: a call to action. Clin J Am Soc Nephrol. 2018; 13 ( 12 ): 1909 ‐ 1911.
dc.identifier.citedreferenceAmaral S, McCulloch CE, Black E, et al. Trends in living donation by race and ethnicity among children with end‐stage renal disease in the United States, 1995–2015. Transplant Direct. 2020; 6 ( 7 ): e570.
dc.identifier.citedreferenceGarg AX, Levey AS, Kasiske BL, et al. Application of the 2017 KDIGO guideline for the evaluation and care of living kidney donors to clinical practice. Clin J Am Soc Nephrol. 2020; 15 ( 6 ): 896 ‐ 905.
dc.identifier.citedreferenceInker LA, Koraishy FM, Goyal N, Lentine KL. Assessment of glomerular filtration rate and end‐stage kidney disease risk in living kidney donor candidates: a paradigm for evaluation, selection, and counseling. Adv Chronic Kidney Dis. 2018; 25 ( 1 ): 21 ‐ 30.
dc.identifier.citedreferenceOPTN (Organ Procurement and Transplantation Network)/UNOS (United Network for Organ Sharing). OPTN policies, policy 14: living donation. http://optn.transplant.hrsa.gov/governance/policies/. Accessed September 12, 2020
dc.identifier.citedreferenceKarger AB, Inker LA, Coresh J, Levey AS, Eckfeldt JH. Novel filtration markers for GFR estimation. EJIFCC. 2017; 28 ( 4 ): 277 ‐ 288.
dc.identifier.citedreferenceHuang N, Foster MC, Lentine KL, et al. Estimated GFR for living kidney donor evaluation. Am J Transplant. 2016; 16 ( 1 ): 171 ‐ 180.
dc.identifier.citedreferenceLevey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150 ( 9 ): 604 ‐ 612.
dc.identifier.citedreferenceLevey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130 ( 6 ): 461 ‐ 470.
dc.identifier.citedreferenceBukabau JB, Yayo E, Gnionsahe A, et al. Performance of creatinine‐ or cystatin C‐based equations to estimate glomerular filtration rate in sub‐Saharan African populations. Kidney Int. 2019; 95 ( 5 ): 1181 ‐ 1189.
dc.identifier.citedreferenceLevey AS, Titan SM, Powe NR, Coresh J, Inker LA. Kidney disease, race, and GFR estimation. Clin J Am Soc Nephrol. 2020; 15 ( 8 ): 1203 ‐ 1212.
dc.identifier.citedreferenceEneanya ND, Yang W, Reese PP. Reconsidering the consequences of using race to estimate kidney function. JAMA. 2019; 322 ( 2 ): 113 ‐ 114.
dc.identifier.citedreferenceVyas DA, Eisenstein LG, Jones DS. Hidden in plain sight — reconsidering the use of race correction in clinical algorithms. N Engl J Med. 2020; 383: 874 ‐ 882.
dc.identifier.citedreferenceNKF and ASN form joint task force to focus on use of race in eGFR. Kidney News Online. 8/24/20. Accessed: 9/12/2020; 2020.
dc.identifier.citedreferencePeralta CA, Shlipak MG, Fan D, et al. Risks for end‐stage renal disease, cardiovascular events, and death in Hispanic versus non‐Hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006; 17 ( 10 ): 2892 ‐ 2899.
dc.working.doi10.7302/120en
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ctr14136.pdf
Size:
556.8KB
Format:
PDF
View/Open
Name:
ctr14136_am.pdf
Size:
319.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.